The NMJI
VOLUME 20, NUMBER 6

NOVEMBER/DECEMBER  2007


MASALA    
    [PDF]  314

Eat wise to prevent diabetes. What is the role of dietary glycaemic index and glycaemic load in the development of type 2 diabetes mellitus, especially in populations that traditionally subsist on a diet high in carbohydrates? Two recent studies have addressed this issue. In one study, some 40 000 black women without diabetes completed food-frequency questionnaires and then were followed for about 8 years. After adjustment for confounders including age and body mass index (BMI), the risk for type 2 diabetes increased as dietary glycaemic index increased. Conversely, risk decreased as consumption of cereal fibre increased (Arch Intern Med 2007;167:2304–9). In the second study that followed some 64 000 Chinese women over 5 years, glycaemic index and intake of carbohydrates (particularly rice) were positively associated with the development of type 2 diabetes (Arch Intern Med 2007;167:2310–16).

Even respiratory infections have cardiovascular consequences. Risks for myocardial infarction and stroke are substantially elevated (odds ratio >3) in the month after a respiratory infection. These results come from a case–control analysis based in a large general practice database in the UK that included over 20 000 cases as well as matched controls, over a 10-year period. The authors concluded that ‘the benefits of reducing respiratory infection either through immunization or treating or preventing infection may be substantial’ (Eur Heart J, 6 Dec 2007 doi:10.1093/eurheartj/ehm516).

The most effective treatment for alcohol-dependent patients with liver cirrhosis is abstinence from alcohol. A randomized, placebo-controlled study investigated the effectiveness and safety of baclofen in achieving and maintaining abstinence from alcohol in patients with cirrhosis of the liver. The baclofen group had a higher rate of achieving and maintaining abstinence (71% v. 29%) and a longer length of cumulative abstinence (Lancet 2007;370:1915–22).

It is well known that more frequent haemodialysis (e.g. daily dialysis) can improve both the survival and quality of life of patients with chronic kidney disease. This will mandate the development of new means of delivering haemodialysis. A small study assessed the safety and efficiency of an experimental wearable haemodialysis device. Eight patients with end-stage renal disease wore the device (powered by a standard 9-volt battery and weighing about 5 kg) for 4–8 hours. There were no important cardiovascular changes and no adverse changes in serum electrolytes or acid–base balance. A comment in the same issue calls the work ‘a small first step in the long road to wearable blood-cleansing devices’. Though small, it is definitely an exciting innovation (Lancet 2007;370: 2005–10).

Adults should not be screened for asymptomatic carotid artery stenosis (CAS). The US Preventive Services Task Force (USPSTF) examined the evidence on the natural history of CAS—systematic reviews of the accuracy of screening tests, observational studies of the harms of screening and treatment of asymptomatic CAS, and randomized, controlled trials of the benefits of treatment for CAS with carotid endarterectomy. The task force concluded that duplex ultrasonography leads to many false-positive results thereby leading to unnecessary confirmatory cerebral angio-graphies or possibly unnecessary carotid endarterectomies. It was estimated that more than 4000 people would need to be screened to prevent 1 stroke over 5 years. It is perhaps more prudent to focus on optimal medical management of the risk factors of stroke (Ann Intern Med 2007;147:854–9).

No more pricks for prophylaxis of deep vein thrombosis. Dabigatran etexilate, an oral, direct thrombin inhibitor that does not require monitoring or dose adjustment was studied for its potential utility for prophylaxis against venous thrombo-embolism (J Thromb Haemost 2007;5:2178–85). In the RE-MODEL trial, over 2000 subjects were randomized to receive dabigatran etexilate or enoxaparin after total knee replacement surgery. Dabigatran etexilate was at least as effective and with a similar safety profile as enoxaparin for the prevention of venous thromboembolism after total knee-replacement surgery.

Yet another ‘scopy’—breast ductoscopy. This involves endoscopy of the female breast. Breast ductoscopy derives from the recent technical developments in ductoscopes and micro-instruments. Diagnostic ductoscopy is now performed by many breast physicians worldwide and interventional ductoscopy depends on an additional working channel and a variety of micro-instruments 0.4–0.8 mm in size for procedures inside the breast duct. Autofluorescence ductoscopy is a new imaging technique that could be used to identify intraductal lesions. Laser ductoscopy for removal of intraductal papillomas and 3-dimensional intraductal tracking systems are the future in this field (Onkologie 2007; 30:545–9).

The conventional bedside manner of the practising clinician stands challenged. Clinicians frequently warn patients of discomfort before potentially painful procedures. A study compared two communications (one with, and the other without, a warning of a ‘sting’) immediately before i.v. cannulation in order to measure differences in perceived pain by patients during the procedure (Br J Anaesth 2007;99:871–5). The communication immediately before i.v. cannulation consisted of either ‘I am going to apply the tourniquet and insert the needle in a few moments. It’s a sharp scratch and it may sting a little’ (Group S) or ‘I am going to apply the tourniquet on the arm. As I do this many people find the arm becomes heavy, numb and tingly. This allows the drip to be placed more comfortably’ (Group NS). The results showed that warning patients of a ‘sting’ before i.v. cannulation may not be helpful and more patients vocalized their pain or withdrew the arm in the warning group (Group S).

 


GOPESH K.MODI

 



         

Search
NMJI Web
 
Email Email this article
Download Add to Favourites
Print Print this Article
write Write to us
write Top
Contact Us | Site Map | Feedback | Disclaimer